Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
A database of clinical trials and their results from Australia, New Zealand, and other countries.
account_circle
Log in
to register or update your trial
search
Search for trials
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT05132582
Registration number
NCT05132582
Ethics application status
Date submitted
12/11/2021
Date registered
24/11/2021
Date last updated
3/06/2025
Titles & IDs
Public title
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Query!
Scientific title
A Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy for Metastatic HER2+ Breast Cancer (HER2CLIMB-05)
Query!
Secondary ID [1]
0
0
C4251007
Query!
Secondary ID [2]
0
0
SGNTUC-028
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
HER2CLIMB-05
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
HER2 Positive Breast Cancer
0
0
Query!
Condition category
Condition code
Cancer
0
0
0
0
Query!
Breast
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Drugs - Tucatinib
Treatment: Drugs - Trastuzumab
Treatment: Drugs - Pertuzumab
Treatment: Drugs - Combination product: Trastuzumab + Pertuzumab
Treatment: Drugs - Placebo
Experimental: Tucatinib + trastuzumab + pertuzumab - Tucatinib + trastuzumab + pertuzumab
Active comparator: Placebo + trastuzumab + pertuzumab - Placebo + trastuzumab + pertuzumab
Treatment: Drugs: Tucatinib
300mg given by mouth (orally) twice daily
Treatment: Drugs: Trastuzumab
6mg/kg given into the vein (IV; intravenously) or 600mg injected under the skin (SC; subcutaneous) every 21 days
Treatment: Drugs: Pertuzumab
420mg given by IV every 21 days
Treatment: Drugs: Combination product: Trastuzumab + Pertuzumab
600 mg pertuzumab, 600 mg trastuzumab, and 20,000 units hyaluronidase will be given by subcutaneous injection every 21 days. May be given in place of trastuzumab and pertuzumab individually.
Treatment: Drugs: Placebo
Given orally twice daily
Query!
Intervention code [1]
0
0
Treatment: Drugs
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Progression-free survival (PFS) by investigator assessment per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1
Query!
Assessment method [1]
0
0
The time from the date of randomization to the investigator assessment of disease progression according to RECIST v1.1 or death from any cause
Query!
Timepoint [1]
0
0
Up to approximately 3 years
Query!
Secondary outcome [1]
0
0
Overall survival (OS)
Query!
Assessment method [1]
0
0
The time from randomization to death from any cause.
Query!
Timepoint [1]
0
0
Up to approximately 5 years
Query!
Secondary outcome [2]
0
0
PFS by blinded independent central review (BICR) per RECIST v1.1
Query!
Assessment method [2]
0
0
The time from the date of randomization to the documented disease progression assessed by BICR according to RECIST v1.1 or death from any cause
Query!
Timepoint [2]
0
0
Up to approximately 3 years
Query!
Secondary outcome [3]
0
0
Time to deterioration of health-related quality of life (HRQoL)
Query!
Assessment method [3]
0
0
Will be measured based on patient reported outcomes (PROs) according to the European Organization for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ C30).
Query!
Timepoint [3]
0
0
Up to approximately 3 years
Query!
Secondary outcome [4]
0
0
Central nervous system (CNS) PFS
Query!
Assessment method [4]
0
0
The time from randomization to investigator assessed disease progression in brain (RECIST v1.1), or death from any cause
Query!
Timepoint [4]
0
0
Up to approximately 3 years
Query!
Secondary outcome [5]
0
0
Incidence of adverse events (AEs)
Query!
Assessment method [5]
0
0
Any untoward medical occurrence in a clinical investigational participant administered a medicinal product and which does not necessarily have a causal relationship with this treatment.
Query!
Timepoint [5]
0
0
Through 30 days after last study treatment, approximately 18 months
Query!
Secondary outcome [6]
0
0
Incidence of laboratory abnormalities
Query!
Assessment method [6]
0
0
To be summarized using descriptive statistics.
Query!
Timepoint [6]
0
0
Through 30 days after last study treatment, approximately 18 months
Query!
Secondary outcome [7]
0
0
Incidence of tucatinib dose alterations
Query!
Assessment method [7]
0
0
To be summarized using descriptive statistics.
Query!
Timepoint [7]
0
0
Through 30 days after last study treatment, approximately 18 months
Query!
Secondary outcome [8]
0
0
Incidence of trastuzumab dose alterations
Query!
Assessment method [8]
0
0
To be summarized using descriptive statistics.
Query!
Timepoint [8]
0
0
Through 30 days after last study treatment, approximately 18 months
Query!
Secondary outcome [9]
0
0
Incidence of pertuzumab dose alterations
Query!
Assessment method [9]
0
0
To be summarized using descriptive statistics.
Query!
Timepoint [9]
0
0
Through 30 days after last study treatment, approximately 18 months
Query!
Secondary outcome [10]
0
0
Maximum concentration (Cmax)
Query!
Assessment method [10]
0
0
To be summarized using descriptive statistics.
Query!
Timepoint [10]
0
0
Through 30 days after last study treatment, approximately 18 months
Query!
Secondary outcome [11]
0
0
Trough concentration (Ctrough)
Query!
Assessment method [11]
0
0
To be summarized using descriptive statistics.
Query!
Timepoint [11]
0
0
Through 30 days after last study treatment, approximately 18 months
Query!
Eligibility
Key inclusion criteria
* Centrally confirmed HER2+ breast carcinoma according to the 2018 American Society of Clinical Oncologists (ASCO) College of American Pathologists (CAP) guidelines prior to randomization (defined as a 3+ score on immunohistochemistry (IHC) and/or 2+ IHC and concurrent positive by ISH).
* Have unresectable locally advanced or metastatic disease.
* If recurrent (after [neo]adjuvant therapy), must be at least 6 month treatment free from any trastuzumab and pertuzumab received in the early breast cancer setting for advanced HER2+ disease.
* Have received 4-8 cycles of pre-study induction therapy including only trastuzumab, pertuzumab, and taxane as first-line of therapy for the treatment of advanced breast cancer prior to study enrollment. Participants are eligible provided they are without evidence of disease progression following completion of induction therapy.
* Known hormone receptor status (per local guidelines; may be hormone receptor positive [HR+] or negative [HR-])
* Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1
* CNS Inclusion - Based on screening contrast-enhanced brain magnetic resonance imaging (MRI), participants may have any of the following:
* No evidence of brain metastases
* Untreated brain metastases which are asymptomatic not needing immediate local treatment and, if identified on prior brain imaging, without evidence of progression since starting first-line induction therapy with trastuzumab, pertuzumab, and taxane
* Previously treated brain metastases which are asymptomatic
* Brain metastases previously treated with local therapy must not have progressed since treatment
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
* Prior treatment with any tyrosine kinase inhibitor targeting HER2 and/or epidermal growth factor receptor (EGFR) including pyrotinib, lapatinib, tucatinib, neratinib, and afatinib (except neratinib if given in extended adjuvant setting and = 12 months have elapsed since last neratinib dose prior to start of study drug)
* Unable to undergo contrast-enhanced MRI of the brain
* CNS Exclusion - Based on screening brain MRI and clinical assessment
* Symptomatic brain metastasis after CNS-directed local therapy
* Progression of brain metastases since starting first line trastuzumab, pertuzumab, and taxane
* Ongoing use of systemic corticosteroids at a total daily dose of >2 mg of dexamethasone (or equivalent)
* Any untreated brain lesion in an anatomic site which may pose risk to participant
* Known or suspected leptomeningeal disease (LMD)
* Poorly controlled (>1/week) seizures, or other persistent neurologic symptoms
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Active, not recruiting
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
7/03/2022
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
28/09/2027
Query!
Actual
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
654
Query!
Recruitment in Australia
Recruitment state(s)
NSW,SA,VIC,WashingtonWA
Query!
Recruitment hospital [1]
0
0
Chris O'Brien Lifehouse - Camperdown
Query!
Recruitment hospital [2]
0
0
Macquarie University Clinical Trials Unit. - Macquarie University
Query!
Recruitment hospital [3]
0
0
Macquarie University Hospital - Macquarie University
Query!
Recruitment hospital [4]
0
0
Baxter Healthcare Pty Limited - Old Tonggabbie
Query!
Recruitment hospital [5]
0
0
Pharmacy Macquarie University Hospital - Sydney
Query!
Recruitment hospital [6]
0
0
Westmead Hospital - Sydney
Query!
Recruitment hospital [7]
0
0
Western Sydney Local Health District (WSLHD), Westmead Hospital - Westmead
Query!
Recruitment hospital [8]
0
0
Cancer Research SA - Adelaide
Query!
Recruitment hospital [9]
0
0
HPS Pharmacies -Adelaide (South Tee) (lnvestigational Product storage and dispensing) - Adelaide
Query!
Recruitment hospital [10]
0
0
St Andrews Medical Centre - Adelaide
Query!
Recruitment hospital [11]
0
0
Flinders Medical Centre - Bedford Park
Query!
Recruitment hospital [12]
0
0
Box Hill Hospital - Box Hill
Query!
Recruitment hospital [13]
0
0
Austin Health - Heidelberg
Query!
Recruitment hospital [14]
0
0
St John of God Subiaco Hospital Clinical Trials Unit Bendat Family Comprehensive Cancer Centre - Subiaco
Query!
Recruitment hospital [15]
0
0
St John of God Subiaco Hospital - Subiaco
Query!
Recruitment postcode(s) [1]
0
0
2050 - Camperdown
Query!
Recruitment postcode(s) [2]
0
0
2109 - Macquarie University
Query!
Recruitment postcode(s) [3]
0
0
2146 - Old Tonggabbie
Query!
Recruitment postcode(s) [4]
0
0
2109 - Sydney
Query!
Recruitment postcode(s) [5]
0
0
2145 - Sydney
Query!
Recruitment postcode(s) [6]
0
0
2145 - Westmead
Query!
Recruitment postcode(s) [7]
0
0
5000 - Adelaide
Query!
Recruitment postcode(s) [8]
0
0
5042 - Bedford Park
Query!
Recruitment postcode(s) [9]
0
0
3128 - Box Hill
Query!
Recruitment postcode(s) [10]
0
0
3084 - Heidelberg
Query!
Recruitment postcode(s) [11]
0
0
6008 - Subiaco
Query!
Recruitment outside Australia
Country [1]
0
0
United States of America
Query!
State/province [1]
0
0
Arizona
Query!
Country [2]
0
0
United States of America
Query!
State/province [2]
0
0
Arkansas
Query!
Country [3]
0
0
United States of America
Query!
State/province [3]
0
0
California
Query!
Country [4]
0
0
United States of America
Query!
State/province [4]
0
0
Florida
Query!
Country [5]
0
0
United States of America
Query!
State/province [5]
0
0
Georgia
Query!
Country [6]
0
0
United States of America
Query!
State/province [6]
0
0
Illinois
Query!
Country [7]
0
0
United States of America
Query!
State/province [7]
0
0
Kentucky
Query!
Country [8]
0
0
United States of America
Query!
State/province [8]
0
0
Maryland
Query!
Country [9]
0
0
United States of America
Query!
State/province [9]
0
0
Minnesota
Query!
Country [10]
0
0
United States of America
Query!
State/province [10]
0
0
Missouri
Query!
Country [11]
0
0
United States of America
Query!
State/province [11]
0
0
Nebraska
Query!
Country [12]
0
0
United States of America
Query!
State/province [12]
0
0
New Jersey
Query!
Country [13]
0
0
United States of America
Query!
State/province [13]
0
0
New York
Query!
Country [14]
0
0
United States of America
Query!
State/province [14]
0
0
Ohio
Query!
Country [15]
0
0
United States of America
Query!
State/province [15]
0
0
Tennessee
Query!
Country [16]
0
0
United States of America
Query!
State/province [16]
0
0
Washington
Query!
Country [17]
0
0
United States of America
Query!
State/province [17]
0
0
Wisconsin
Query!
Country [18]
0
0
Austria
Query!
State/province [18]
0
0
Other
Query!
Country [19]
0
0
Austria
Query!
State/province [19]
0
0
Graz
Query!
Country [20]
0
0
Austria
Query!
State/province [20]
0
0
Linz
Query!
Country [21]
0
0
Austria
Query!
State/province [21]
0
0
Schwaz
Query!
Country [22]
0
0
Austria
Query!
State/province [22]
0
0
Wien
Query!
Country [23]
0
0
Belgium
Query!
State/province [23]
0
0
Brussels
Query!
Country [24]
0
0
Belgium
Query!
State/province [24]
0
0
Oost-vlaanderen
Query!
Country [25]
0
0
Belgium
Query!
State/province [25]
0
0
Walloon Brabant
Query!
Country [26]
0
0
Belgium
Query!
State/province [26]
0
0
Anderlecht
Query!
Country [27]
0
0
Belgium
Query!
State/province [27]
0
0
Brussel
Query!
Country [28]
0
0
Belgium
Query!
State/province [28]
0
0
Ottignies
Query!
Country [29]
0
0
Brazil
Query!
State/province [29]
0
0
Ceara
Query!
Country [30]
0
0
Brazil
Query!
State/province [30]
0
0
Goias
Query!
Country [31]
0
0
Brazil
Query!
State/province [31]
0
0
Other
Query!
Country [32]
0
0
Brazil
Query!
State/province [32]
0
0
Parana
Query!
Country [33]
0
0
Brazil
Query!
State/province [33]
0
0
RIO Grande DO Norte
Query!
Country [34]
0
0
Brazil
Query!
State/province [34]
0
0
RIO Grande DO SUL
Query!
Country [35]
0
0
Brazil
Query!
State/province [35]
0
0
SAO Paulo
Query!
Country [36]
0
0
Brazil
Query!
State/province [36]
0
0
Porto Alegre/RS
Query!
Country [37]
0
0
Brazil
Query!
State/province [37]
0
0
Sao Jose do Rio Preto
Query!
Country [38]
0
0
Brazil
Query!
State/province [38]
0
0
Sao Paulo
Query!
Country [39]
0
0
Brazil
Query!
State/province [39]
0
0
São Paulo/SP
Query!
Country [40]
0
0
Brazil
Query!
State/province [40]
0
0
São Paulo
Query!
Country [41]
0
0
Canada
Query!
State/province [41]
0
0
Alberta
Query!
Country [42]
0
0
Canada
Query!
State/province [42]
0
0
British Columbia
Query!
Country [43]
0
0
Canada
Query!
State/province [43]
0
0
Ontario
Query!
Country [44]
0
0
Canada
Query!
State/province [44]
0
0
Quebec
Query!
Country [45]
0
0
Chile
Query!
State/province [45]
0
0
Cautin
Query!
Country [46]
0
0
Chile
Query!
State/province [46]
0
0
Santiago
Query!
Country [47]
0
0
Chile
Query!
State/province [47]
0
0
Valparaíso
Query!
Country [48]
0
0
Chile
Query!
State/province [48]
0
0
Talca
Query!
Country [49]
0
0
Chile
Query!
State/province [49]
0
0
Temuco
Query!
Country [50]
0
0
China
Query!
State/province [50]
0
0
Anhui
Query!
Country [51]
0
0
China
Query!
State/province [51]
0
0
Guangdong
Query!
Country [52]
0
0
China
Query!
State/province [52]
0
0
Guangxi
Query!
Country [53]
0
0
China
Query!
State/province [53]
0
0
Hainan
Query!
Country [54]
0
0
China
Query!
State/province [54]
0
0
Hebei
Query!
Country [55]
0
0
China
Query!
State/province [55]
0
0
Henan
Query!
Country [56]
0
0
China
Query!
State/province [56]
0
0
Hubei
Query!
Country [57]
0
0
China
Query!
State/province [57]
0
0
Hunan
Query!
Country [58]
0
0
China
Query!
State/province [58]
0
0
Jiangsu
Query!
Country [59]
0
0
China
Query!
State/province [59]
0
0
Jiangxi
Query!
Country [60]
0
0
China
Query!
State/province [60]
0
0
Jilin
Query!
Country [61]
0
0
China
Query!
State/province [61]
0
0
Liaoning
Query!
Country [62]
0
0
China
Query!
State/province [62]
0
0
Other
Query!
Country [63]
0
0
China
Query!
State/province [63]
0
0
Shaanxi
Query!
Country [64]
0
0
China
Query!
State/province [64]
0
0
Shandong
Query!
Country [65]
0
0
China
Query!
State/province [65]
0
0
Zhejiang
Query!
Country [66]
0
0
China
Query!
State/province [66]
0
0
Beijing
Query!
Country [67]
0
0
China
Query!
State/province [67]
0
0
Binjiang District
Query!
Country [68]
0
0
China
Query!
State/province [68]
0
0
Changchun
Query!
Country [69]
0
0
China
Query!
State/province [69]
0
0
Nanjing
Query!
Country [70]
0
0
China
Query!
State/province [70]
0
0
Nanning
Query!
Country [71]
0
0
China
Query!
State/province [71]
0
0
Shanghai
Query!
Country [72]
0
0
China
Query!
State/province [72]
0
0
Tianjin City
Query!
Country [73]
0
0
Czechia
Query!
State/province [73]
0
0
Praha 2
Query!
Country [74]
0
0
Czechia
Query!
State/province [74]
0
0
Brno
Query!
Country [75]
0
0
Czechia
Query!
State/province [75]
0
0
Praha 4 - Krc
Query!
Country [76]
0
0
Czechia
Query!
State/province [76]
0
0
Praha 5 - Motol
Query!
Country [77]
0
0
Finland
Query!
State/province [77]
0
0
Tampere
Query!
Country [78]
0
0
France
Query!
State/province [78]
0
0
Bretagne
Query!
Country [79]
0
0
France
Query!
State/province [79]
0
0
Cedex
Query!
Country [80]
0
0
France
Query!
State/province [80]
0
0
Languedoc-roussillon
Query!
Country [81]
0
0
France
Query!
State/province [81]
0
0
Loire-atlantique
Query!
Country [82]
0
0
France
Query!
State/province [82]
0
0
Lyon
Query!
Country [83]
0
0
France
Query!
State/province [83]
0
0
Mainet-et-loire
Query!
Country [84]
0
0
France
Query!
State/province [84]
0
0
Avignon Cedex 9
Query!
Country [85]
0
0
France
Query!
State/province [85]
0
0
Besancon
Query!
Country [86]
0
0
France
Query!
State/province [86]
0
0
Besangon
Query!
Country [87]
0
0
France
Query!
State/province [87]
0
0
Bobigny
Query!
Country [88]
0
0
France
Query!
State/province [88]
0
0
Caen Cedex 5
Query!
Country [89]
0
0
France
Query!
State/province [89]
0
0
Caen
Query!
Country [90]
0
0
France
Query!
State/province [90]
0
0
Clermont Ferrand
Query!
Country [91]
0
0
France
Query!
State/province [91]
0
0
Clermont-Ferrand
Query!
Country [92]
0
0
France
Query!
State/province [92]
0
0
Dijon
Query!
Country [93]
0
0
France
Query!
State/province [93]
0
0
Lille
Query!
Country [94]
0
0
France
Query!
State/province [94]
0
0
Montpellier Cedex 5
Query!
Country [95]
0
0
France
Query!
State/province [95]
0
0
Montpellier
Query!
Country [96]
0
0
France
Query!
State/province [96]
0
0
Nice cedex 2
Query!
Country [97]
0
0
France
Query!
State/province [97]
0
0
Nice
Query!
Country [98]
0
0
France
Query!
State/province [98]
0
0
Paris
Query!
Country [99]
0
0
France
Query!
State/province [99]
0
0
Pierre Benite
Query!
Country [100]
0
0
France
Query!
State/province [100]
0
0
Plerin
Query!
Country [101]
0
0
France
Query!
State/province [101]
0
0
Rennes
Query!
Country [102]
0
0
France
Query!
State/province [102]
0
0
Rouen
Query!
Country [103]
0
0
France
Query!
State/province [103]
0
0
Saint-Cloud
Query!
Country [104]
0
0
France
Query!
State/province [104]
0
0
Strasbourg
Query!
Country [105]
0
0
France
Query!
State/province [105]
0
0
Île-de-france
Query!
Country [106]
0
0
Germany
Query!
State/province [106]
0
0
North Rhine-westphalia
Query!
Country [107]
0
0
Germany
Query!
State/province [107]
0
0
Other
Query!
Country [108]
0
0
Germany
Query!
State/province [108]
0
0
Augsburg
Query!
Country [109]
0
0
Germany
Query!
State/province [109]
0
0
Berlin
Query!
Country [110]
0
0
Germany
Query!
State/province [110]
0
0
Hamburg
Query!
Country [111]
0
0
Germany
Query!
State/province [111]
0
0
Manheim
Query!
Country [112]
0
0
Germany
Query!
State/province [112]
0
0
Muenchen
Query!
Country [113]
0
0
Germany
Query!
State/province [113]
0
0
Munster
Query!
Country [114]
0
0
Germany
Query!
State/province [114]
0
0
Ulm
Query!
Country [115]
0
0
Germany
Query!
State/province [115]
0
0
Wurzburg
Query!
Country [116]
0
0
Greece
Query!
State/province [116]
0
0
Attica
Query!
Country [117]
0
0
Greece
Query!
State/province [117]
0
0
Peloponnese
Query!
Country [118]
0
0
Greece
Query!
State/province [118]
0
0
Larissa
Query!
Country [119]
0
0
Greece
Query!
State/province [119]
0
0
Maroussi
Query!
Country [120]
0
0
Greece
Query!
State/province [120]
0
0
Pireaus
Query!
Country [121]
0
0
Italy
Query!
State/province [121]
0
0
Campania
Query!
Country [122]
0
0
Italy
Query!
State/province [122]
0
0
Liguria
Query!
Country [123]
0
0
Italy
Query!
State/province [123]
0
0
Lombardia
Query!
Country [124]
0
0
Italy
Query!
State/province [124]
0
0
Lombardy
Query!
Country [125]
0
0
Italy
Query!
State/province [125]
0
0
Marche
Query!
Country [126]
0
0
Italy
Query!
State/province [126]
0
0
Monza AND Brianza
Query!
Country [127]
0
0
Italy
Query!
State/province [127]
0
0
Sicily
Query!
Country [128]
0
0
Italy
Query!
State/province [128]
0
0
Trentino
Query!
Country [129]
0
0
Italy
Query!
State/province [129]
0
0
Tuscany
Query!
Country [130]
0
0
Italy
Query!
State/province [130]
0
0
Bologna
Query!
Country [131]
0
0
Italy
Query!
State/province [131]
0
0
Genova
Query!
Country [132]
0
0
Italy
Query!
State/province [132]
0
0
Milano
Query!
Country [133]
0
0
Italy
Query!
State/province [133]
0
0
Milan
Query!
Country [134]
0
0
Italy
Query!
State/province [134]
0
0
Parma
Query!
Country [135]
0
0
Italy
Query!
State/province [135]
0
0
Pavia
Query!
Country [136]
0
0
Japan
Query!
State/province [136]
0
0
Chiba-ken
Query!
Country [137]
0
0
Japan
Query!
State/province [137]
0
0
Chiba
Query!
Country [138]
0
0
Japan
Query!
State/province [138]
0
0
Ehime-ken
Query!
Country [139]
0
0
Japan
Query!
State/province [139]
0
0
Ehime
Query!
Country [140]
0
0
Japan
Query!
State/province [140]
0
0
Fukuoka
Query!
Country [141]
0
0
Japan
Query!
State/province [141]
0
0
Fukushima
Query!
Country [142]
0
0
Japan
Query!
State/province [142]
0
0
Hokkaido
Query!
Country [143]
0
0
Japan
Query!
State/province [143]
0
0
Ishikawa
Query!
Country [144]
0
0
Japan
Query!
State/province [144]
0
0
Kanagawa
Query!
Country [145]
0
0
Japan
Query!
State/province [145]
0
0
Lbaraki-ken
Query!
Country [146]
0
0
Japan
Query!
State/province [146]
0
0
Okinawa-ken
Query!
Country [147]
0
0
Japan
Query!
State/province [147]
0
0
Okinawa
Query!
Country [148]
0
0
Japan
Query!
State/province [148]
0
0
Osaka-fu
Query!
Country [149]
0
0
Japan
Query!
State/province [149]
0
0
Tokyo-to
Query!
Country [150]
0
0
Japan
Query!
State/province [150]
0
0
Tokyo
Query!
Country [151]
0
0
Korea, Republic of
Query!
State/province [151]
0
0
Chungcheongbuk-do
Query!
Country [152]
0
0
Korea, Republic of
Query!
State/province [152]
0
0
Gangwon-do
Query!
Country [153]
0
0
Korea, Republic of
Query!
State/province [153]
0
0
Gyeonggi-do
Query!
Country [154]
0
0
Korea, Republic of
Query!
State/province [154]
0
0
Gyeonggido [kyonggi-do]
Query!
Country [155]
0
0
Korea, Republic of
Query!
State/province [155]
0
0
Busan
Query!
Country [156]
0
0
Korea, Republic of
Query!
State/province [156]
0
0
Incheon
Query!
Country [157]
0
0
Korea, Republic of
Query!
State/province [157]
0
0
Seoul
Query!
Country [158]
0
0
Netherlands
Query!
State/province [158]
0
0
Zuid-holland
Query!
Country [159]
0
0
Netherlands
Query!
State/province [159]
0
0
Dordrecht
Query!
Country [160]
0
0
Netherlands
Query!
State/province [160]
0
0
Utrecht
Query!
Country [161]
0
0
Netherlands
Query!
State/province [161]
0
0
Venlo
Query!
Country [162]
0
0
Poland
Query!
State/province [162]
0
0
Gdansk
Query!
Country [163]
0
0
Poland
Query!
State/province [163]
0
0
Lodz
Query!
Country [164]
0
0
Poland
Query!
State/province [164]
0
0
Opole
Query!
Country [165]
0
0
Poland
Query!
State/province [165]
0
0
Slaskie
Query!
Country [166]
0
0
Portugal
Query!
State/province [166]
0
0
Braga
Query!
Country [167]
0
0
Portugal
Query!
State/province [167]
0
0
Coimbra
Query!
Country [168]
0
0
Portugal
Query!
State/province [168]
0
0
Lisboa
Query!
Country [169]
0
0
Portugal
Query!
State/province [169]
0
0
Lisbon
Query!
Country [170]
0
0
Spain
Query!
State/province [170]
0
0
Comunidad Valenciana
Query!
Country [171]
0
0
Spain
Query!
State/province [171]
0
0
Islas Baleares
Query!
Country [172]
0
0
Spain
Query!
State/province [172]
0
0
Murcia
Query!
Country [173]
0
0
Spain
Query!
State/province [173]
0
0
Santa CRUZ DE Tenerife
Query!
Country [174]
0
0
Spain
Query!
State/province [174]
0
0
Barcelona
Query!
Country [175]
0
0
Spain
Query!
State/province [175]
0
0
Bilbao
Query!
Country [176]
0
0
Spain
Query!
State/province [176]
0
0
Caceres
Query!
Country [177]
0
0
Spain
Query!
State/province [177]
0
0
Girona
Query!
Country [178]
0
0
Spain
Query!
State/province [178]
0
0
Granada
Query!
Country [179]
0
0
Spain
Query!
State/province [179]
0
0
Lleida
Query!
Country [180]
0
0
Spain
Query!
State/province [180]
0
0
Madrid
Query!
Country [181]
0
0
Spain
Query!
State/province [181]
0
0
Malaga
Query!
Country [182]
0
0
Spain
Query!
State/province [182]
0
0
Salamanca
Query!
Country [183]
0
0
Spain
Query!
State/province [183]
0
0
Sevilla
Query!
Country [184]
0
0
Spain
Query!
State/province [184]
0
0
Valencia
Query!
Country [185]
0
0
Switzerland
Query!
State/province [185]
0
0
Zurich
Query!
Country [186]
0
0
Switzerland
Query!
State/province [186]
0
0
Baden
Query!
Country [187]
0
0
Switzerland
Query!
State/province [187]
0
0
Zürich
Query!
Country [188]
0
0
Taiwan
Query!
State/province [188]
0
0
Changhua City
Query!
Country [189]
0
0
Taiwan
Query!
State/province [189]
0
0
Kaohsiung
Query!
Country [190]
0
0
Taiwan
Query!
State/province [190]
0
0
New Taipei City
Query!
Country [191]
0
0
Taiwan
Query!
State/province [191]
0
0
Taichung
Query!
Country [192]
0
0
Taiwan
Query!
State/province [192]
0
0
Tainan City
Query!
Country [193]
0
0
Taiwan
Query!
State/province [193]
0
0
Tainan
Query!
Country [194]
0
0
Taiwan
Query!
State/province [194]
0
0
Taipei City
Query!
Country [195]
0
0
Taiwan
Query!
State/province [195]
0
0
Taipei
Query!
Country [196]
0
0
Taiwan
Query!
State/province [196]
0
0
Taoyuan City
Query!
Country [197]
0
0
United Kingdom
Query!
State/province [197]
0
0
England
Query!
Country [198]
0
0
United Kingdom
Query!
State/province [198]
0
0
Surrey
Query!
Country [199]
0
0
United Kingdom
Query!
State/province [199]
0
0
London
Query!
Country [200]
0
0
United Kingdom
Query!
State/province [200]
0
0
Manchester
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Query!
Name
Seagen, a wholly owned subsidiary of Pfizer
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
This study is being done to see if tucatinib works better than placebo when given with other drugs to treat participants with HER2-positive breast cancer. A placebo is a pill that looks the same as tucatinib but has no medicine in it. This study will also test what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides treating your disease. Participants will have cancer that has spread in the body near where it started (locally advanced) and cannot be removed (unresectable) or has spread through the body (metastatic). In this study, all participants will get either tucatinib or placebo. Participants will be assigned randomly to a group. This is a blinded study, so patients and their doctors will not know which group a participant is in. All participants will also get trastuzumab and pertuzumab. These are 2 drugs used to treat this type of cancer.
Query!
Trial website
https://clinicaltrials.gov/study/NCT05132582
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Pfizer CT.gov Call Center
Query!
Address
0
0
Pfizer
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Seagen Trial Information Support
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
866-333-7436
Query!
Fax
0
0
Query!
Email
0
0
[email protected]
Query!
Contact person for scientific queries
Data sharing statement
Will individual participant data (IPD) for this trial be available (including data dictionaries)?
Yes
Query!
What data in particular will be shared?
Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests.
Query!
When will data be available (start and end dates)?
Query!
Available to whom?
Query!
Available for what types of analyses?
Query!
How or where can data be obtained?
IPD available at link: https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests
Query!
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
No documents have been uploaded by study researchers.
Results not provided in
https://clinicaltrials.gov/study/NCT05132582
Download to PDF